Investigation of anticancer drug lapatinib and its interaction with dsDNA by electrochemical and spectroscopic techniques

Ciardiello, 2001, A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor, Clin. Cancer Res., 7, 2958 Goustin, 1986, Growth factors and cancer, Cancer Res., 46, 1015 Moyer, 1997, Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase, Cancer Res., 57, 4838 Rusnak, 2001, The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo, Mol. Cancer Ther., 1, 85 Pedersen, 2001, The type III epidermal growth factor receptor mutation: biological significance and potential target for anti-cancer therapy, Ann. Oncol., 12, 745, 10.1023/A:1011177318162 Xia, 2002, Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways, Oncogene, 21, 6255, 10.1038/sj.onc.1205794 Rusnak, 2001, The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer, Cancer Res., 61, 7196 Cockerill, 2001, Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2, Bioorg. Med. Chem. Lett., 11, 1401, 10.1016/S0960-894X(01)00219-0 Burris, 2004, Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib, Oncology, 9, 10, 10.1634/theoncologist.9-suppl_3-10 Hsieh, 2004, Increasing throughput of parallel on-line extraction liquid chromatography/electrospray ionization tandem mass spectrometry system for GLP quantitative bioanalysis in drug development, Rapid Commun. Mass Spectrom., 18, 285, 10.1002/rcm.1327 Bai, 2006, Determination of lapatinib (GW572016) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC–ESI-MS/MS), J. Chromatogr. B, 831, 169, 10.1016/j.jchromb.2005.11.044 Ozkan, 2012 Wang, 1998 Oliviera Brett, 1997, Comparison of the voltammetric behavior of metronidazole at a DNA-modified glassy carbon electrode, a mercury thin film electrode and a glassy carbon electrode, Electroanalysis, 9, 110, 10.1002/elan.1140090204 Erdem, 2002, Electrochemical DNA biosensors based on DNA-drug interactions, Electroanalysis, 14, 965, 10.1002/1521-4109(200208)14:14<965::AID-ELAN965>3.0.CO;2-U Wang, 1996, Accumulation and trace measurements of phenothiazine drugs at DNA-modified electrodes, Anal. Chim. Acta, 332, 139, 10.1016/0003-2670(96)00248-6 Teijeiro, 2000, Electrochemical analysis of anthramycin: hydrolysis, DNA-interactions and quantitative determination, Electroanalysis, 12, 963, 10.1002/1521-4109(200008)12:12<963::AID-ELAN963>3.0.CO;2-B Oliveria Brett, 1996, Electrochemical determination of carboplatin in serum using a DNA-modified glassy carbon electrode, Electroanalysis, 8, 992, 10.1002/elan.1140081104 Wang, 2006, Electrochemical biosensors: towards point-of-care cancer diagnostics, Biosens. Bioelectron., 21, 1887, 10.1016/j.bios.2005.10.027 Palecek, 1960, Oscillographic polarography of highly polymerized deoxyribonucleic acid, Nature, 188, 656, 10.1038/188656a0 Diculescu, 2006, Voltammetric behavior of antileukemia drug Glivec. Part I – electrochemical study of Glivec, Electroanalysis, 18, 1800, 10.1002/elan.200603591 Brett, 1993, Cyclic voltammetry and linear sweep techniques Gosser, 1993 Ozkan, 2004, Electroanalytical characteristics of amisulpride and voltammetric determination of the drug in pharmaceuticals and biological media, Electroanalysis, 16, 231, 10.1002/elan.200402828 Demircigil, 2003, Voltammetric oxidation of ambroxol and application to its determination in pharmaceuticals and in drug dissolution studies, Electroanalysis, 15, 230, 10.1002/elan.200390029 Moane, 1995, Electrochemical behaviour of clenbuterol at nation-modified carbon-paste electrodes, J. Pharm. Biomed. Anal., 14, 57, 10.1016/0731-7085(95)01610-4 Sharma, 1976, Anodic oxidation of p-anisidines at the tubular graphite electrode, Electrochim. Acta, 21, 1085, 10.1016/0013-4686(76)85090-6 McGrath, 1996, Investigation of the electrochemical oxidation of clenbuterol at a porous carbon electrode, and its application to the determination of this β-agonist in bovine hair by liquid chromatography with coulometric detection, Anal. Chim. Acta, 322, 159, 10.1016/0003-2670(95)00602-8 Wang, 2001, Determination of trace metoclopramide by anodic stripping voltammetry with nafion modified glassy carbon electrode, Talanta, 53, 1133, 10.1016/S0039-9140(00)00519-1 Lund, 2001 Grimshaw, 2000 Sirajuddin, 2013, Drug–DNA interactions and their study by UV–vis, fluorescence spectroscopies and cyclic voltammetry, J. Photochem. Photobiol. B: Biol., 124, 1, 10.1016/j.jphotobiol.2013.03.013 Carter, 1989, Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2′-bipyridine, J. Am. Chem. Soc., 111, 8901, 10.1021/ja00206a020 Zhou, 2005, Electrochemical studies of danthron and the DNA–danthron interaction, Biophys. Chem., 114, 21, 10.1016/j.bpc.2004.11.001 Wang, 2010, Investigation of the interaction of carbofuran and DNA by voltammetry and fluorescence with the aid of chemometrics, Chin. Chem. Lett., 21, 963, 10.1016/j.cclet.2010.03.015 Li, 1997, Study on the interaction between rivanol and DNA and its application to DNA assay, Spectrochim. Acta A, 53, 781, 10.1016/S1386-1425(97)00015-2 Liu, 2002, Molecular recognition and complexation thermodynamics of dye guest molecules by modified cyclodextrins and calixarenesulfonates, J. Phys. Chem. B, 106, 4678, 10.1021/jp015603r